Evidence and anecdotes: an analysis of human gene patenting controversies
Evidence and anecdotes: an analysis of human gene patenting controversies | Nature
Biotechnology Skip to main content Thank you for visiting nature.com. You are using a browser …
Biotechnology Skip to main content Thank you for visiting nature.com. You are using a browser …
The intellectual commons and property in synthetic biology
KA Oye, R Wellhausen - Synthetic Biology: the technoscience and its …, 2010 - Springer
Is the development of synthetic biology threatened by sharing and ownership issues? What
measures are synthetic biologists taking to address intellectual property and commons …
measures are synthetic biologists taking to address intellectual property and commons …
Synthetic biology and intellectual property rights: Six recommendations
In September 2014 the European Commission's Scientific Committees published a Final
Opinion, which defines synthetic biology (SB) as follows:“SynBio is the application of …
Opinion, which defines synthetic biology (SB) as follows:“SynBio is the application of …
The BRCA patent controversies: an international review of patent disputes
The discovery of the two inherited susceptibility genes BRCA1 and BRCA2 in the mid-1990s
created the possibility of predictive genetic testing and led to the establishment of specific …
created the possibility of predictive genetic testing and led to the establishment of specific …
[PDF][PDF] Vom Lesen zur Literaturwissenschaft: ein Beitrag zum DaF-Lesen aus belgischer Sicht
R Duhamel - Literatur in Europa: Schulpraxis, Geschichte …, 1994 - repository.uantwerpen.be
A book focusing on transnational perspectives on BRCA would certainly be incomplete
without a chapter on the international uproar regarding patents on the BRCA gene …
without a chapter on the international uproar regarding patents on the BRCA gene …
[PDF][PDF] Breast Cancer Gene Research and Medical Practices
A book focusing on transnational perspectives on BRCA would certainly be incomplete
without a chapter on the international uproar regarding patents on the BRCA gene …
without a chapter on the international uproar regarding patents on the BRCA gene …
[PDF][PDF] Cease or Persist? Gene Patents and the Clinical Diagnostics Dilemma
C Lee - 2012 - elischolar.library.yale.edu
Patent protections on biomedical innovations help incentivize the development of new
devices and drugs. In the field of clinical diagnostics, however, patents on human DNA can …
devices and drugs. In the field of clinical diagnostics, however, patents on human DNA can …
Compulsory Licensing as a price control and supply policy of patented drugs: Is it a possible alternative in South Korea?
JO Byeon, JH Chung - Health Policy and Management, 2010 - koreascience.kr
Korea has had problems with the price and supply of essential drugs such as Gleevec for
leukemia, Fuzeon for HIV/AIDS, and Tamiflu for both avian flu and swine flu. The shortage or …
leukemia, Fuzeon for HIV/AIDS, and Tamiflu for both avian flu and swine flu. The shortage or …
硏究ㆍ試驗을위한特許發明의實施와特許權의效力
조영선 - 저스티스, 2010 - dbpia.co.kr
이 논문은 연구ㆍ시험을 위한 특허발명의 실시와 특허권의 효력 제한의 문제를 다룬다. 이와
관련하여 실무상 주로 문제되는 첫 번째는 후발 제약업자가 복제약의 생산을 위하여 특허권 …
관련하여 실무상 주로 문제되는 첫 번째는 후발 제약업자가 복제약의 생산을 위하여 특허권 …
[PDF][PDF] THE INTELLECTUAL COMMONS AND PROPERTY IN SYNTHETIC BIOLOGY
R WELLHAUSEN, KA OYE - rwellhausen.com
Is the development of synthetic biology threatened by sharing and ownership issues? What
measures are synthetic biologists taking to address intellectual property and commons …
measures are synthetic biologists taking to address intellectual property and commons …